Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells

Hongxia Shang1, Junyu Zhao1,2, Jinming Yao1,2

  • 1Division of Endocrinology, Department of Internal Medicine, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.

Thoracic Cancer
|October 22, 2019
PubMed
Abstract

Insights

Nevirapine effectively suppresses thyroid cancer metastasis by inhibiting cell migration and invasion. This novel therapy shows promise for treating aggressive thyroid cancers, particularly those that have spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Thyroid cancer metastasis is aggressive and often radioiodine resistant.
  • Current therapies for metastatic thyroid cancer are limited.
  • Nevirapine's anti-cancer effects are known, but its role in thyroid cancer metastasis was unexplored.

Purpose of the Study:

  • To investigate the efficacy of nevirapine in suppressing migration and invasion of dedifferentiated thyroid cancer cells.
  • To evaluate nevirapine's impact on thyroid cancer liver metastasis in a preclinical model.

Main Methods:

  • Utilized WRO 82-1 dedifferentiated thyroid cancer cell line.
  • Performed real-time quantitative PCR, western blot, and transwell migration/invasion assays.
  • Assessed liver metastasis in nude mouse xenografts using hematoxylin-eosin staining.

Main Results:

  • Nevirapine significantly reduced migration and invasion in WRO 82-1 cells.
  • Nevirapine markedly decreased liver metastasis in a mouse model.
  • Observed decreased IL-6 mRNA expression and reduced JAK2/STAT3 pathway activation.

Conclusions:

  • Nevirapine inhibits thyroid cancer cell migration, invasion, and metastasis.
  • The mechanism involves the downregulation of the IL-6/STAT3 signaling pathway.
  • Nevirapine presents potential as a novel therapeutic agent for metastatic thyroid cancer.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.1K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K